MIRM vs PKI
Mirum Pharmaceuticals Inc (MIRM) versus PKI (PKI) — a side-by-side from cached financials, not a winner call.
Mirum Pharmaceuticals Inc (MIRM) is a biotechnology company listed on NASDAQ.
PKI (PKI) common stock.
Latest reported MIRM revenue for 2026-06-30 was $336.1M. Net income was -$857.4M. MIRM currently screens at market cap $6.22B.
PKI does not have a complete income-statement cache yet.
MIRM currently screens at market cap $6.22B.
Not investment advice. Open the MIRM and PKI stock pages for the full models.
Not investment advice.